Compositions and methods for treating diseases of the nail
DC CAFCFirst Claim
Patent Images
1. A method for the treatment of onychomycosis comprising topically applying to the surface of the nail of an individual suffering from onychomycosis a pharmaceutical composition comprising:
- 50% w/w to 70% w/w ethanol,8% w/w to 15% w/w diisopropyl adipate,8% w/w to 15% w/w C12-15 alkyl lactate,10% w/w to 15% w/w cyclomethicone, and2% w/w to 15% w/w (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidine-1-yl)-1-(1H-1,2,4-triazole-1-yl)butane-2-ol;
wherein the composition is formulated as a solution; and
wherein the application of the composition is in an amount and for a time sufficient to ameliorate the symptoms of the onychomycosis.
14 Assignments
Litigations
0 Petitions
Accused Products
Abstract
Methods and compositions for treating disorders of the nail and nail bed. Such compositions contain a vehicle in which all components of the composition are dissolved, suspended, dispersed, or emulsified, a non-volatile solvent, a wetting agent, and a pharmaceutically active ingredient that is soluble in the non-volatile solvent and/or a mixture of the vehicle and the non-volatile solvent, and which composition is effective in treating a disorder of the nail or nail bed.
30 Citations
14 Claims
-
1. A method for the treatment of onychomycosis comprising topically applying to the surface of the nail of an individual suffering from onychomycosis a pharmaceutical composition comprising:
-
50% w/w to 70% w/w ethanol, 8% w/w to 15% w/w diisopropyl adipate, 8% w/w to 15% w/w C12-15 alkyl lactate, 10% w/w to 15% w/w cyclomethicone, and 2% w/w to 15% w/w (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidine-1-yl)-1-(1H-1,2,4-triazole-1-yl)butane-2-ol; wherein the composition is formulated as a solution; and wherein the application of the composition is in an amount and for a time sufficient to ameliorate the symptoms of the onychomycosis. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)
-
-
14. A method for the treatment of onychomycosis comprising topically applying to the surface of the nail of an individual suffering from onychomycosis a pharmaceutical composition comprising:
-
50% w/w to 70% w/w ethanol, about 12% w/w diisopropyl adipate, about 10% w/w C12-15 alkyl lactate, about 13% w/w cyclomethicone, and about 10% w/w (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidine-1-yl)-1-(1H-1,2,4-triazole-1-yl)butane-2-ol; wherein the composition is formulated as a solution; and wherein the application of the composition is in an amount and for a time sufficient to ameliorate the symptoms of the onychomycosis.
-
Specification